last week i noted recently published article found studies favoring gsk mood stabilizer lamictal tended get published medical journals articles reaching less favorable conclusions tended remained unpublished i wrote gsk worked system expertly paid reader commented thought characterization gsk hiding negative data lamictal inaccurate i appreciate well written critical comments linked partially reproduced acute depression acute depression studies reported presented scientific meetings years recently published bipolar disorders calabrese et al long publish paper rejected twice took years get accepted journal reviewers find data interest i responded via comment history accurate reviewers flogged added gsk provided negative lamictal data numerous authors wrote review articles lamictal cases appears true however least one notable case either gsk failed provide data authors completely ignored negative data data appeared academic highlight i lowlight journal clinical psychiatry relevance article funded unrestricted educational grant gsk article bashes antidepressant treatment bipolar unsupported evidence expert panel authors key opinion leaders put together guidelines treating bipolar disorder article begins discussing bipolar depression lithium discussed first receives positive review comes lamictal gsk mood stabilizer discuss detail positive results calabrese et al authors discuss positive long term findings lamotrigine moving olanzapine olanzapine fluoxetine conclude lithium lamictal best evidence treating bipolar depression seen category evidence best evidence hooray lamotrigine lamictal discuss expert review data two negative studies sca completed scab completed gsk titles studies showed negative results lamictal treating depression bipolar disorder reader tracked sent find head gsk clinical trial registry given international consensus guidelines published february think authors would included data gsk unpublished studies unless know existence would unless gsk told knew opted include expert review given gsk employee told me open honest gsk data i interested seeing response believes took place keep mind journal clinical psychiatry called academic highlight appeared widely read journal according google scholar piece cited times many doubtlessly recycled inaccurate claim lamictal effective treatment acute bipolar depression pattern usual company conducts research selectively publishes positive results funds educational pieces academic highlights paint overly rosy picture treatment effectiveness safety physicians based upon evidence base delude thinking writing prescriptions based best scientific data